A Boron‐Dependent Antibiotic Derived from a Calcium‐Dependent Antibiotic
Angewandte Chemie International Edition · 2024
DOI: 10.1002/anie.202317522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Shao-Lun Chiou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei City, 10617, Taiwan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
The prevalence of drug‐resistant bacterial pathogens foreshadows a healthcare crisis. Calcium‐dependent antibiotics (CDAs) are promising candidates to combat infectious diseases as many of them show modes of action (MOA) orthogonal to widespread resistance mechanisms. The calcium dependence is nonetheless one of the hurdles toward realizing their full potential. Using laspartomycin C (LspC) as a model, we explored the possibility of reducing, or even eliminating, its calcium dependence. We report herein a synthetic LspC analogue ( B1 ) whose activity no longer depends on calcium and is instead induced by phenylboronic acid (PBA). In LspC, Asp1 and Asp7 coordinate to calcium to anchor it in the active conformation; these residues are replaced by serine in B1 and condense with PBA to form a boronic ester with the same anchoring effect. Using thin‐layer chromatography, MS, NMR, and complementation assays, we demonstrate that B1 inhibits bacterial growth via the same MOA as LspC, i.e., sequestering the cell wall biosynthetic intermediate undecaprenyl phosphate. B1 is as potent and effective as LspC against several Gram‐positive bacteria, including methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant Enterococcus . Our success in converting a CDA to a boron‐dependent antibiotic opens a new avenue in the design and functional control of drug molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei City, 10617, Taiwan.
- Department of Chemistry, Tufts University, 62 Talbot Avenue, Medford, MA 02155, USA.
ORCID-Profile: Shao-Lun Chiou, Minh Ngoc Ho, Jiayuan Miao, Yu-Shan Lin, John Chu
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Chiou, S. L., Chen, Y. J., Lee, C. T., Ho, M. N., Miao, J., Kuo, P. C., Hsu, C. C., Lin, Y. S., & Chu, J. (2024). A Boron‐Dependent Antibiotic Derived from a Calcium‐Dependent Antibiotic. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202317522
Vancouver
Chiou SL, Chen YJ, Lee CT, Ho MN, Miao J, Kuo PC, et al. A Boron‐Dependent Antibiotic Derived from a Calcium‐Dependent Antibiotic. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202317522
BibTeX
@article{Chiou2024,
author = {Chiou, Shao-Lun and Chen, Yi-Ju and Lee, Chu-Ting and Ho, Minh Ngoc and Miao, Jiayuan and Kuo, Po-Cheng and Hsu, Cheng-Chih and Lin, Yu-Shan and Chu, John},
title = {A Boron‐Dependent Antibiotic Derived from a Calcium‐Dependent Antibiotic},
journal = {Angewandte Chemie International Edition},
year = {2024},
doi = {10.1002/anie.202317522}
}
EUVIMED